Study creates first 3D vision of cancer target
A team from the Department of Molecular and Cell Biology has for the first time published a detailed description of a protein linked to many types of cancer.
The lab-based study now provides an opportunity for scientists to develop drugs to target this protein.
Dr Cyril Dominguez who led the work at Leicester said: “The proteins that we have studied, called Sam68 and T-STAR, are very similar and overexpression of Sam68 has been shown to correlate with poor prognosis in many types of cancers.
“Our results provide atomic resolution details on how Sam68 binds specifically to its RNA target. Furthermore, we show that Sam68 forms a homodimer that has never been described before and is crucial for its function in RNA splicing.
“This is important because this basic research set the grounds for structure-based drug design approaches. If we can identify or design drugs that bind specifically at the dimerization interface, we will be able to prevent the function of these proteins in cells, which could have implications for novel cancer treatments."
Dr Dominguez’s work has been published in Nature Communications and is funded by the Medical Research Council.